PDGFRB and Wilson disease: The combination of WD and CCl4 produces robust HSC activation marked by increased expression of genes for collagen I, alpha smooth muscle actin (αSMA), and platelet derived growth factor receptor beta (PDGFRβ) (Fig 1E).